ClinConnect ClinConnect Logo
Search / Trial NCT04441112

Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial

Launched by SAINT ALPHONSUS REGIONAL MEDICAL CENTER · Jun 18, 2020

Trial Information

Current as of July 21, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Symptomatic, radiographically proven degenerative joint disease in the hip or knee
  • Exclusion Criteria:
  • recent injection in the hip or knee within the previous 3 months
  • history of traumatic osteoarthritis or ligamentous reconstruction
  • chronic narcotic use
  • history of inflammatory or neuropathic arthropathy
  • pregnant and/or nursing women
  • allergy or strong reaction to study medications

About Saint Alphonsus Regional Medical Center

Saint Alphonsus Regional Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor, the center focuses on a diverse range of therapeutic areas, leveraging its state-of-the-art facilities and a multidisciplinary team of experts to conduct rigorous, ethically sound research. Committed to enhancing healthcare delivery, Saint Alphonsus fosters collaboration among clinicians, researchers, and the community, aiming to translate scientific discoveries into effective treatments and improved quality of care for patients.

Locations

Boise, Idaho, United States

Patients applied

0 patients applied

Trial Officials

Kevin Jurgensmeier, BS

Principal Investigator

Student Investigator at Saint Alphonsus Regional Medical Center

Steven B Daines, MD

Study Chair

Surgeon at Saint Alphonsus Regional Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials